Responsibility for the diagnosis and management of disorders of the pulmonary circulation has become the shared domain of the pulmonologist, cardiologist, surgeon, radiologist, pathologist, and, perhaps most important of all, the internist.
Because the increasing complexities of diagnos- testing and training, for example) are of neces- ing and treating coronary artery disease are at sity discussed in more than one chapter with times overwhelming for many physicians, the appropriate cross referencing.
It has been known or suspected for centuries that there is an association between mind and emotions and the occurrence of heart disease apd sudden death.
A recent comprehensive study of stress and human health by the Institute of Medicine/National Academy of Sciences concludes that individuals who experience any of a wide range of stressful events or situations are at increased risk of developing a physical or mental disorder, including heart disease.
These Proceedings are from the Fifth Annual Meeting of the American Section of the International Society for Heart Research held at Hilton Head Island, South Carolina, September 21-24, 1983.
In 1628 William Harvey published his discovery of the existence of the microcirculation which he deduced from careful anatomical and physiological study.
The first two "e;Brain Heart Conferences"e; in Jerusalem in 1978 and 1983 were based upon the common interests of clinically orientated neurologists and cardiologists in the problems of centr'al autonomic control and autonomic disturbances of the cardiovascular system.
Attention to reducing the major risk factors Contemporary coronary care involves a associated with the development of arterio- multitude of measures: efforts to prevent the sclerosis has been widespread and appears to acute event; thrombolytic therapy to abort have lowered the incidence of coronary artery infarction; pharmacological measures to delay disease.
Some 25 years ago, the coronary care unit concentrated high technology and the acutely ill patients who might benefit from it in a single, recognizable space.
This symposium is devoted to Biotechnology in Blood Transfusion; there are 22 experts discussing the state of the art in the application of monoclonal anti- bodies, recombinant DNA technologies and heterologous expression systems to the improvement and sometimes replacement of blood products, charac- terization of blood constituents, and the effect of these developments on blood transfusion procedures.
The importance of heart and artery disease as a cause of death and disability is difficult to exaggerate: it causes over half of all deaths in the western world and now accounts for one-quarter of deaths in the entire world.
It is indeed ironical that in the absence of a complete knowledge of Pathophysiology, clinical cardiologists are left with no choice but to do the best they can to help the patient with the armamentarium of drugs at their disposal.
The Stressed Heart is truly unique in concept and will provide an eXCItmg adventure to the reader no matter what his or her field of expertise and interest.
Almost every effort in the care of patients with heart disease begins with some description of disordered physiologic performance or mor- phologic anatomy.
Sir Dominic Corrigan's classic monograph "e;On Permanent Patency of the Mouth of the Aorta, or Inadequacy of the Aortic Valves"e; was published in 1832.
Although some investigators have questioned the importance and even the existence of silent myocardial ischemia, documentation presented at this two day symposium leaves little doubt about its existence and importance.
This volume contains the lectures presented at the International School of Radiation Damage and Protection at the "e;Ettore Majorana"e; Centre for Sci- entific Culture in Erice, Italy, September 6-15, 1985.
The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and members of the Food and Drug Administration to discuss important clinical research issues.
This monograph contains 20 selected papers presented at the Symposium on Subcellular Basis of Contractile Failure which was held in Ottawa during May 11-13, 1989 and is designed for the benefit ofthose who were unable to attend this event.
The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues.
Following the advent of percutaneous balloon vel oped and are available for clinical use, as well angioplasty, interventional cardiovascular pro- as those that are still in investigational phases.
